Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9493-9501

  Ponnazhagan, S ^a   Mahendra, G ^a   Curiel, D T ^a   Shaw, D R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ALLERGY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DNA MODIFICATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; CELL DIFFERENTIATION; DENDRITIC CELLS; DEPENDOVIRUS; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; MONOCYTES; TRANSFECTION;

EID: 0034856182     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9493-9501.2001     Document Type: Article

References (56)

1. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors
2. A comparison of gene transfer methods in human dendritic cells
3. Immunobiology of dendritic cells
4. Dendritic cells and the control of immunity
5. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders
6. Dendritic cells
7. Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy
8. Dendritic cells pulsed with RNA are potent antigen presenting cells in vitro and in vivo
9. Failure of cancer vaccines: The significant limitations of this approach in immunotherapy
10. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration
11. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors
12. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity
13. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
14. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue
15. Secondstrand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
16. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
17. Novel tools for production and purification of recombinant adeno associated virus vectors
18. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
19. Selective extraction of polyoma DNA from infected mouse cell cultures
20. In vivo detection of dendritic cell antigen presentation to CD4+ T cells
21. Poxvirus as a vector to transduce human dendritic ells for immunotherapy: Abortive infection but reduced APC function
22. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
23. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo
24. Migration patterns of dendritic cells in the mouse: Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues
25. Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus
26. Protein measurement with the folin phenol reagent
27. Adeno-associated virus type 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression
28. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D
29. An innate sense of danger
30. Use of adeno-associated virus as a general transduction vector for mammalian cells
31. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
32. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wildtype AAV
33. Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100
34. Impairment of force generation after adenovirus mediated gene transfer to muscle is alleviated by adenoviral gene-inactivation and host CD8+T cell deficiency
35. L increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice
36. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells
37. Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice
38. Adeno-associated virus 2-mediated transduction of primary human bone marrow derived CD34+ hematopoietic progenitor cells: Donor variation and correlation of expression with cellular differentiation
39. Adeno-associated virus 2-mediated transduction of murine repopulating hematopoietic stem cells and long-term expression of a human globin gene in vivo
40. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukemia cells are non-permissive for AAV infection
41. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients
42. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
43. Adeno-associated virus vectors and hematology
44. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
45. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
46. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are nducible in terminal stage HLA-A2.1 + melanoma patients by mature monocyte-derived dendritic cells
47. Adeno-associated virus-mediated gene delivery
48. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
49. Sustained secretion of human alpha-1 antitrypsin from murine muscle transduced with adeno-associated virus vectors
50. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: Comparison with adenovirus vectors
51. Dendritic cell vaccines for cancer immunotherapy
52. Gene-based strategies for the immunotherapy of cancer
53. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination
54. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple specifications and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3
55. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
56. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: Role of immature dendritic cells